FDA Approves Vaprisol

Vaprisol Astellas Pharma US, Inc. - Treatment for Euvolemic Hyponatremia

Vaprisol is an arginine vasopressin (AVP) antagonist indicated for the treatment of euvolemic hyponatremia in hospitalized patients.

Posted: December 2005

Related Articles:

Vaprisol (conivaptan hydrochloride) FDA Approval History

View comments

Hide
(web1)